跳至主要内容
临床试验/EUCTR2021-002789-42-AT
EUCTR2021-002789-42-AT进行中(未招募)1 期

Analysis and characterization of the immune response after influenza, SARS-CoV-2 and pneumococcal vaccinations (IMMUNE Study)

Medizinische Universität Innsbruck0 个研究点目标入组 1,000 人开始时间: 2021年7月7日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Age (= 18 years)
  • 2. Decision-making male and female Subjects
  • 3. Has there been influenza, or SARS-CoV-2, or Pneumococcal vaccination (collective 1 + 2) or already fixed vaccination date with an influenza, or
  • SARS-CoV-2, or pneumococcal vaccination (Collective 1)
  • 4. Written, signed and dated Declaration of consent to participate in the clinical examination after prior written and oral explanation
  • 5. Only applicable to subjects in collective 1: negative urine / serum pregnancy test Women of childbearing age
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 800
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 200

排除标准

  • Exclusion criteria
  • 1. The subject is a presence or Training service provider
  • 2. Parallel vaccination with a second vaccine within ± 14 days
  • 3. Participation in an interventional study in the active phase
  • 4. Only applicable to subjects in collective 1: Breastfeeding period

研究者

相似试验